The EVAPIL scale, a new tool to assess tolerance of oral contraceptives.

Background: The EVAPIL scale is a self-questionnaire aimed to assess tolerability of oral contraceptives (OC).

Methods: For initial development: a list of questions addressing the more frequent or more unpleasant minor side effects of OC was developed by a group of gynecologists and submitted to several sets of OC users. A final version with 14 questions was issued with scoring rules.

[Uterine and ovarian necrosis following embolisation of the uterine arteries for postpartum haemorrhagia].

We report here the case of a young woman who presented with pain, fever and apparent cutaneous sub ischaemia following embolisation of the uterine arteries for postpartum haemorrhagia. This embolisation was carried out by bilateral selective catheterism of the uterine arteries using 45 to 150 micron polyvinyl alcohol particles. Investigative laparotomy was decided in view of the persistence of the symptoms, and the patient underwent hysterectomy with ablation of the right adnexa to treat uterine necrosis and adnexal atrophy.

[Pregnancies occurring during oral contraception: lessons from the GRECO study].

Objectives: The GRECO study has collected data on pregnancies, regardless of their outcome, that occurred in women taking an oral contraceptive.

Patients And Methods: The analysis concerned 551 women prospectively recruited in services of gynaecology or obstetrics, termination of pregnancy centres, family planning centres or consultations of gynaecology in France throughout 2002 and who were 12 weeks pregnant or less.

Results: Contraception used during the cycle of conception was an estroprogestative combination in 88% of cases, a microprogestative in 8.

[Preliminary results from the OPNI observatory: long-term follow-up of a cohort of women using the progestagen contraceptive implant Implanon].

Objective: Describe the initiation and follow-up of Implanon insertion in current office-based practice in France and estimate the rate and causes of early removals.

Patients And Methods: A prospective cohort study of 1000 women having been inserted with Implanon by a representative national sample of prescribers (gynaecologists and general practitioners) was designed. The follow-up period was 3 years and the enrolment was planned for 2 years starting July 2002 according to a naturalistic design.